A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors
Clinical trial NCT05143970 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05143970
- Sponsor
- Institut Paoli-Calmettes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-21
- Primary completion
- 2027-03-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.